APT(SH:688617) Sou Hu Cai Jing·2025-08-22 11:52Company Overview - Shenzhen Huatai Medical Co., Ltd. specializes in the research, production, and sales of electrophysiological and interventional medical devices [1] - The main products include electrophysiological catheters, coronary access devices, peripheral vascular interventional devices, and non-vascular interventional medical devices [1] - The company is recognized for its innovative products, being the first domestic manufacturer to obtain registration certificates for electrophysiological electrode mapping catheters and radiofrequency ablation electrode catheters [1] Financial Performance - For the first half of 2025, the company reported a revenue of 1.214 billion yuan, representing a year-on-year increase of 21.26% [1] - The net profit for the same period was 425 million yuan, showing a year-on-year growth of 24.11% [1] - The gross profit margin stood at 73.51% [1] Market Position - As of August 22, the company's stock closed at 280.59 yuan, down 1.20%, with a rolling price-to-earnings (PE) ratio of 52.35 times [1] - The total market capitalization is approximately 39.567 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical device sector is 56.95 times, with a median of 40.49 times, placing Huatai Medical at the 90th position in the industry ranking [1][2] Shareholder Information - As of June 30, 2025, the number of shareholders increased to 4,507, up by 755 from the previous count [1] - The average market value of shares held by each shareholder is 352,800 yuan, with an average holding of 27,600 shares [1]